U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Guidance for Industry: Implementation of Section 10809 of the Farm Security and Investment Act of 2002 Regarding the Petition Process to Request Approval of Labeling for Foods that Have Been Treated with Irradiation
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Guidance for Industry: Implementation of Section 10809 of the Farm Security and Investment Act of 2002 Regarding the Petition Process to Request Approval of Labeling for Foods that Have Been Treated with Irradiation October 2002

Read the Federal Register Notice
Final
Docket Number:
FDA-2002-D-0189
Issued by:
Guidance Issuing Office
Human Foods Program

This guidance represents the agency's current thinking on this subject. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statutes and regulations.

This guidance is part of FDA's implementation of section 10809 of the Farm Security and Investment Act of 2002, Pub. L. No. 101-171, § 10809 (2002). Section 10809, which was enacted on May 13, 2002, directs FDA to publish a proposed rule and, with due consideration to public comment, a final rule to revise, as appropriate, the current regulation governing the labeling of foods that have been treated by irradiation. This provision further states that "[p]ending promulgation of the final rule..., any person may petition the Secretary [FDA] for approval of labeling, which is not false or misleading in any material respect, of a food which has been treated by irradiation using radioactive isotope, electronic beam, or x-ray." Section 10809 also requires that, pending promulgation of the final rule, "{t}he Secretary [FDA] shall approve or deny such a petition within 180 days of receipt of the petition, or the petition shall be deemed denied, except to the extent additional agency review is mutually agreed upon by the Secretary [FDA] and the petitioner."

FDA is issuing this guidance to interested parties who wish to petition the agency for approval of labeling, which is not false or misleading in any material respect, of a food that has been treated by irradiation. FDA recommends that interested parties who wish to petition the agency should use the procedures set forth in § 10.30 (21 CFR 10.30) that outline the requirements for submitting a citizen petition to FDA, except that § 10.30(e)(2)(iii), regarding 180-day tentative responses, does not apply because section 10809 provides that the petition is deemed to be denied if the Secretary [FDA] fails to act on the petition within 180 days of receipt, unless an extension is mutually agreed upon by the parties. Section 10.30 requires the petitioner to submit to the agency all relevant information that supports the petition, including any data, e.g., qualitative or quantitative consumer research, that shows consumer understanding of the purpose and intent of the proposed labeling. Such information might include, but is not limited to, data on consumers' prior assumptions about, and perceptions of, the product characteristics in light of the proposed labeling statements, and data on consumer acceptance of, and comprehension of, the proposed labeling statements in comparison to consumer acceptance of, and comprehension of, the irradiation statement required by the current regulation (21 CFR § 179.26(c)(1)).

This document was issued in October 2002.
See more recent information on Food Labeling.

Related Information

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2002-D-0189.

Back to Top